EPISODE · Nov 24, 2021 · 21 MIN
Doug Drysdale On How CYB-003 Is Better Than Psilocybin
from Psychedelic Spotlight Podcast · host Global Trac Solutions Inc., Psychedelic Spotlight, The Psychedelic Investor, James Hallifax, Doug Drysdale, Cybin
In this episode, James Hallifax from the Psychedelic Investor, interviews Doug Drysdale, CEO of Cybin (NYSE: CYBN). In this fantastic discussion, Doug and James discuss the potential for psilocybin (magic mushrooms) to treat depression and other mental health issues. The conversation then pivots to what Cybin sees as the main issues with psilocybin: its long duration of effect, long period before onset action, and the variability in effects from person to person.*Learn more about Cybin by visiting their website: Cybin.com*Pre-order your Wakeful Travel Psychedelic Integration Journal HERE!*Subscribe to our newsletter to get the latest industry news: PsychedelicSpotlight.com
What this episode covers
Interview with Doug Drysdale, CEO of Cybin
NOW PLAYING
Doug Drysdale On How CYB-003 Is Better Than Psilocybin
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m